The Initiative helps clinicians align their clinical practice with updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Melanoma (Version 1.2026) frameworkProvides T1b and ...
Immunis, Inc., a clinical-stage biotech company targeting age-related diseases, today announced it has entered an exclusive licensing agreement with Toray to develop and commercialize a drug candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results